Literature DB >> 12688649

Reversible myocardial dysfunction after traumatic brain injury: mechanisms and implications for heart transplantation.

Robert T Palac1, Glen Sumner, Rebecca Laird, Daniel J O'Rourke.   

Abstract

Reversible myocardial dysfunction is known to occur in patients with cerebrovascular accidents and brain death. Several mechanisms for transient myocardial dysfunction have been proposed, including increased sympathetic activity, hormone depletion, and a reduction in coronary perfusion pressure. The relative importance of each of these mechanisms remains controversial. We report the case of a 19-year-old man who suffered traumatic brain death associated with reversible myocardial dysfunction despite elevated cardiac enzymes. Myocardial recovery occurred after correcting his hemodynamic instability and hypothermia emphasizing the importance of normalization of coronary perfusion pressure and core body temperature. The mechanisms for reversible myocardial dysfunction and their implications for heart transplantation following traumatic brain death are reviewed. A diagnostic strategy is proposed that would allow early recognition of reversible myocardial dysfunction in brain-dead patients.

Entities:  

Mesh:

Year:  2003        PMID: 12688649     DOI: 10.1177/152692480301300109

Source DB:  PubMed          Journal:  Prog Transplant        ISSN: 1526-9248            Impact factor:   1.065


  2 in total

Review 1.  Takotsubo Cardiomyopathy in Traumatic Brain Injury.

Authors:  Chun Fai Cheah; Mario Kofler; Alois Josef Schiefecker; Ronny Beer; Gert Klug; Bettina Pfausler; Raimund Helbok
Journal:  Neurocrit Care       Date:  2017-04       Impact factor: 3.210

2.  Hyponatremia and comparison of NT-pro-BNP concentrations in blood samples from jugular bulb and arterial sites after traumatic brain injury in adults: a pilot study.

Authors:  David J Powner; Georgene W Hergenroeder; Mustafa Awili; Mustafa A Atik; Claudia Robertson
Journal:  Neurocrit Care       Date:  2007       Impact factor: 3.532

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.